InhaleRX snags $38.5M in funding from VC biotech funder Clendon
InhaleRX is set to go ahead with clinical trials after Victorian VC firm Clendon handed IRX nearly $40M in cash.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results